AT295737B - Process and production of synergistic, orally administrable, polyvalent vaccines which protect against local intestinal infections - Google Patents
Process and production of synergistic, orally administrable, polyvalent vaccines which protect against local intestinal infectionsInfo
- Publication number
- AT295737B AT295737B AT744569A AT744569A AT295737B AT 295737 B AT295737 B AT 295737B AT 744569 A AT744569 A AT 744569A AT 744569 A AT744569 A AT 744569A AT 295737 B AT295737 B AT 295737B
- Authority
- AT
- Austria
- Prior art keywords
- synergistic
- production
- protect against
- orally administrable
- intestinal infections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0283—Shigella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1792256A DE1792256C3 (en) | 1968-08-10 | 1968-08-10 | Orally administered, polyvalent vaccines against local intestinal infections |
Publications (1)
Publication Number | Publication Date |
---|---|
AT295737B true AT295737B (en) | 1972-01-10 |
Family
ID=5707335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT744569A AT295737B (en) | 1968-08-10 | 1969-08-01 | Process and production of synergistic, orally administrable, polyvalent vaccines which protect against local intestinal infections |
Country Status (11)
Country | Link |
---|---|
US (1) | US3651214A (en) |
JP (1) | JPS4819931B1 (en) |
AT (1) | AT295737B (en) |
BE (1) | BE737281A (en) |
BR (1) | BR6911415D0 (en) |
DE (1) | DE1792256C3 (en) |
ES (1) | ES370327A1 (en) |
FR (1) | FR2015423A1 (en) |
GB (1) | GB1282912A (en) |
IL (1) | IL32723A (en) |
NL (1) | NL163426C (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1336015A (en) * | 1970-06-03 | 1973-11-07 | Unilever Ltd | Rearing pigs |
US4057627A (en) * | 1972-03-21 | 1977-11-08 | Helmut Anton Stickl | Acne preparation for oral administration |
US4328209A (en) * | 1979-04-11 | 1982-05-04 | Board Of Regents, The University Of Texas System | Cholera vaccine |
ZA872532B (en) * | 1986-04-21 | 1987-11-25 | Akzo Nv | Combined vaccine |
IT1199301B (en) * | 1986-11-21 | 1988-12-30 | Belfanti Ist Sieroterap Milan | BACTERIAL ANTIGENIC LYSATE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT |
MY128159A (en) * | 2000-06-30 | 2007-01-31 | Wyeth Corp | Methods and composition for oral vaccination |
WO2005086669A2 (en) * | 2004-03-02 | 2005-09-22 | University Of Georgia Research Foundation, Inc. | Hydrogenase deficient bacterial strains |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3139382A (en) * | 1961-10-31 | 1964-06-30 | American Home Prod | Bacterins and process of producing the same |
-
1968
- 1968-08-10 DE DE1792256A patent/DE1792256C3/en not_active Expired
-
1969
- 1969-07-29 IL IL32723A patent/IL32723A/en unknown
- 1969-08-01 AT AT744569A patent/AT295737B/en not_active IP Right Cessation
- 1969-08-07 ES ES370327A patent/ES370327A1/en not_active Expired
- 1969-08-07 US US848349A patent/US3651214A/en not_active Expired - Lifetime
- 1969-08-08 BR BR211415/69A patent/BR6911415D0/en unknown
- 1969-08-08 FR FR6927341A patent/FR2015423A1/fr not_active Withdrawn
- 1969-08-08 BE BE737281D patent/BE737281A/en not_active IP Right Cessation
- 1969-08-08 NL NL6912159.A patent/NL163426C/en not_active IP Right Cessation
- 1969-08-09 JP JP44063240A patent/JPS4819931B1/ja active Pending
- 1969-08-11 GB GB39983/69A patent/GB1282912A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
BE737281A (en) | 1970-02-09 |
IL32723A0 (en) | 1969-09-25 |
GB1282912A (en) | 1972-07-26 |
IL32723A (en) | 1972-11-28 |
DE1792256A1 (en) | 1971-11-04 |
BR6911415D0 (en) | 1973-04-12 |
DE1792256B2 (en) | 1978-11-09 |
US3651214A (en) | 1972-03-21 |
FR2015423A1 (en) | 1970-04-24 |
NL163426C (en) | 1980-09-15 |
DE1792256C3 (en) | 1979-07-05 |
ES370327A1 (en) | 1971-08-01 |
NL163426B (en) | 1980-04-15 |
JPS4819931B1 (en) | 1973-06-18 |
NL6912159A (en) | 1970-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE772190A (en) | NEW PHARMACEUTICAL COMPOSITIONS | |
FI54916B (en) | FRAMEWORK FOR THERAPEUTIC TREATMENT OF NUTRITIONAL N-SUBSTITUTE 2-PYRROLIDONER | |
AT327971B (en) | BLOW PROCESS | |
AT314264B (en) | Process for the protection of veterinary substances against the influence of rumen digestive juice | |
SE7409801L (en) | PROCEDURE FOR THE PREPARATION OF KINOLIN ASSOCIATIONS. | |
BE787901A (en) | ANTIVARIOLIC VACCINE | |
CH501623A (en) | Process for the preparation of 2-chloropyridine and its derivatives | |
AT295737B (en) | Process and production of synergistic, orally administrable, polyvalent vaccines which protect against local intestinal infections | |
SE385267B (en) | STODORGAN FOR PACKAGING OF SHIRTS AND THE LIKE | |
BE782981A (en) | PHARMACEUTICAL COMPOSITIONS | |
BR6457270D0 (en) | PROCESS OF PREPARING A PHARMACEUTICAL COMPOSITION PROVIDING A PROLONGED RELEASE OF A DRUG IN THE INTESTINAL GASTRO SYSTEM | |
BE782444A (en) | PHARMACEUTICAL COMPOSITIONS | |
BE782065A (en) | PHARMACEUTICAL AND VETERINARY COMPOSITIONS | |
FI56866B (en) | SAETT ATT FOERHINDRA UTSLAEPP AV KLORHALTIGA FOERORENINGAR VID SODIUMBASERADE CELLULOSAFABRIKER | |
FI55893C (en) | ANORDNING FOER MINSKNING AV MATNINGSKRAFTEN VID BERGBORRNING | |
FI55334B (en) | PROCEDURE FOR THE FRAMSTATION OF A BUTTER PROCESSING OF A TRIAZOLOBENSODIAZEPINER ANVAENDA 2-ALCOXY-5-PHENYL-3H-1,4-BENZODIAZEPINDERIVAT | |
FI55338B (en) | PROCEDURE FOR THE FRAMEWORK OF THERAPEUTIC VERIFICATION N-METHYL IMIDAZOLER | |
BG20601A3 (en) | REMEDY FOR THE TREATMENT OF ALOPECIA SENILIS | |
FI53368C (en) | FOERFARANDE FOER BESTAEMNING AV AMYLASKONCNTRATION I ETT VAETSKEPROV OCH DEN VID BESTAEMNINGEN ANVAENDA UTFAELLNINGSMEDELSLOESNINGEN | |
FI55971B (en) | TILLSLUTNINGSANORDNING VID LAEMPLIGEN AV WELLPAPP BESTAOENDE LAODFORMIGA EMBALLAGE | |
FI53843C (en) | DRIVANORDNING FOER VAEFTFOERARSTAONGEN VID VAEVSTOLAR MED TVAO INBOERDES MELLANRUM JAEMNLOEPANDE RAKA VAEVBANOR | |
FI53726C (en) | ANORDNING VID BEHAOLLARE FOER BEHANDLING AV CELLULOSAMASSA | |
BE774927A (en) | POLYALKYLENE GLYCOLIC ESTERS OF TERTIARY AMINES AND DERIVATIVES OF THESE ESTERS | |
DE2128626B2 (en) | ORAL LIVE VACCINE AGAINST TYPHUS | |
NL145854B (en) | PROCESS FOR THE PREPARATION OF N-ALKENYL QUINOLONES AND OF PHARMACEUTICAL PREPARATIONS WITH ANTIBACTERIAL ACTION. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EIH | Change in the person of patent owner | ||
EIH | Change in the person of patent owner | ||
ELJ | Ceased due to non-payment of the annual fee |